Skip to main content

John G. Aunins

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John G. Aunins

John G. Aunins was last confirmed as CTO at Seres Therapeutics, Inc. (MCRB) in a filing dated April 30, 2020.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

No call appearances or filed executive changes recorded yet.